Skip to main content
icon for Wie viele Fälle von neuroinvasiven West-Nil-Erkrankungen werden im Jahr 2026 unter den Bewohnern von New York City gemeldet werden?

Wie viele Fälle von neuroinvasiven West-Nil-Erkrankungen werden im Jahr 2026 unter den Bewohnern von New York City gemeldet werden?

icon for Wie viele Fälle von neuroinvasiven West-Nil-Erkrankungen werden im Jahr 2026 unter den Bewohnern von New York City gemeldet werden?

Wie viele Fälle von neuroinvasiven West-Nil-Erkrankungen werden im Jahr 2026 unter den Bewohnern von New York City gemeldet werden?

Weniger als 20 44%

35 bis 49 32%

50 oder mehr 27%

20 bis 34 0

Polymarket
NEU

Weniger als 20 44%

35 bis 49 32%

50 oder mehr 27%

20 bis 34 0

Polymarket
NEU

Weniger als 20

$4 Vol.

44%

20 bis 34

$4 Vol.

40%

35 bis 49

$145 Vol.

32%

50 oder mehr

$181 Vol.

27%

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Recent elevated West Nile virus activity in New York City mosquitoes—over 1,200 positive pools detected by mid-August, nearly double last year’s pace—has raised transmission risk, prompting eight targeted control operations since July. This follows a first human case confirmed August 19 in a resident exposed both locally and externally. Neuroinvasive disease averages rose from 16 cases annually (2012–2021) to 31 (2022–2025) per NYC Health Department data, aligning with national trends showing 156 neuroinvasive cases among 222 total U.S. infections as of August 18. Mosquito surveillance began positive pools in mid-June, consistent with prior seasons, while cooler or wetter late-summer conditions could extend the transmission window through fall. Traders weigh these surveillance signals and recent baseline increases against ongoing larviciding and public precautions, producing closely matched implied probabilities across the sub-20, 20–34, and higher bins as case counts remain early and weather-dependent.

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.

Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.

The 2026 count shown on the source as of January 1, 2027 is the starting figure.

If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.

If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Volumen
$335
Enddatum
31. März 2027
Markt eröffnet
Aug 20, 2026, 5:18 PM ET
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.Recent elevated West Nile virus activity in New York City mosquitoes—over 1,200 positive pools detected by mid-August, nearly double last year’s pace—has raised transmission risk, prompting eight targeted control operations since July. This follows a first human case confirmed August 19 in a resident exposed both locally and externally. Neuroinvasive disease averages rose from 16 cases annually (2012–2021) to 31 (2022–2025) per NYC Health Department data, aligning with national trends showing 156 neuroinvasive cases among 222 total U.S. infections as of August 18. Mosquito surveillance began positive pools in mid-June, consistent with prior seasons, while cooler or wetter late-summer conditions could extend the transmission window through fall. Traders weigh these surveillance signals and recent baseline increases against ongoing larviciding and public precautions, producing closely matched implied probabilities across the sub-20, 20–34, and higher bins as case counts remain early and weather-dependent.

This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page.

Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap.

The 2026 count shown on the source as of January 1, 2027 is the starting figure.

If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time.

If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.
Volumen
$335
Enddatum
31. März 2027
Markt eröffnet
Aug 20, 2026, 5:18 PM ET
This market resolves based on the total number of West Nile neuroinvasive disease cases (encephalitis, meningitis, and acute flaccid paralysis) reported among New York City residents in 2026, as published by the New York City Department of Health and Mental Hygiene on its West Nile Virus Reports page at nyc.gov/site/doh/health/health-topics/west-nile-virus-reports.page. Cases are counted as whole numbers, so each outcome covers a distinct range with no overlap or gap. The 2026 count shown on the source as of January 1, 2027 is the starting figure. If the DOHMH publishes or revises the 2026 count on or after January 1, 2027, this market will resolve based on the count shown on the source at 11:59 PM ET on the 14th day after the first such update, or on March 31, 2027, 11:59 PM ET, whichever comes first. If no such update occurs, this market will resolve on March 31, 2027, 11:59 PM ET, based on the 2026 count shown on the source at that time. If no 2026 count has been published on the source by March 31, 2027, 11:59 PM ET, this market will resolve based on the sum of 2026 West Nile neuroinvasive disease case counts reported by CDC ArboNET for the five New York City counties (Bronx, Kings, New York, Queens, and Richmond). Revisions published after this market resolves will not be considered. If the DOHMH changes its reporting format or URL structure, the closest equivalent NYC Health Department publication of 2026 West Nile neuroinvasive case data will be used.

Vorsicht bei externen Links.

Häufig gestellte Fragen

„Wie viele Fälle von neuroinvasiven West-Nil-Erkrankungen werden im Jahr 2026 unter den Bewohnern von New York City gemeldet werden?" ist ein Prognosemarkt auf Polymarket mit 4 möglichen Ergebnissen, bei dem Händler Anteile auf Basis ihrer Einschätzung kaufen und verkaufen. Das aktuell führende Ergebnis ist „Weniger als 20" mit 44%, gefolgt von „20 bis 34" mit 40%. Die Preise spiegeln Echtzeit-Wahrscheinlichkeiten der Community wider. Ein Anteilspreis von 44¢ bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 44% zuweist. Diese Quoten ändern sich laufend, wenn Händler auf neue Entwicklungen reagieren. Anteile am richtigen Ergebnis können bei Marktauflösung für jeweils $1 eingelöst werden.

„Wie viele Fälle von neuroinvasiven West-Nil-Erkrankungen werden im Jahr 2026 unter den Bewohnern von New York City gemeldet werden?" ist ein neu erstellter Markt auf Polymarket, gestartet am Aug 20, 2026. Als früher Markt haben Sie die Gelegenheit, zu den ersten Händlern zu gehören, die die Quoten setzen und die ersten Preissignale des Marktes etablieren. Sie können diese Seite auch als Lesezeichen speichern, um Volumen und Handelsaktivität zu verfolgen, während der Markt an Fahrt gewinnt.

Um auf „Wie viele Fälle von neuroinvasiven West-Nil-Erkrankungen werden im Jahr 2026 unter den Bewohnern von New York City gemeldet werden?" zu handeln, durchsuchen Sie die 4 verfügbaren Ergebnisse auf dieser Seite. Jedes Ergebnis zeigt einen aktuellen Preis, der die implizierte Wahrscheinlichkeit des Marktes darstellt. Um eine Position einzunehmen, wählen Sie das Ergebnis, das Sie für am wahrscheinlichsten halten, wählen Sie „Ja" um dafür oder „Nein" um dagegen zu handeln, geben Sie Ihren Betrag ein und klicken Sie auf „Handeln". Liegt Ihr gewähltes Ergebnis bei Marktauflösung richtig, zahlen Ihre „Ja"-Anteile jeweils $1 aus. Liegt es falsch, zahlen sie $0. Sie können Ihre Anteile auch jederzeit vor der Auflösung verkaufen.

Der aktuelle Favorit für „Wie viele Fälle von neuroinvasiven West-Nil-Erkrankungen werden im Jahr 2026 unter den Bewohnern von New York City gemeldet werden?" ist „Weniger als 20" mit 44%, was bedeutet, dass der Markt diesem Ergebnis eine Wahrscheinlichkeit von 44% zuweist. Das nächstliegende Ergebnis ist „20 bis 34" mit 40%. Diese Quoten werden in Echtzeit aktualisiert, wenn Händler Anteile kaufen und verkaufen. Schauen Sie regelmäßig vorbei oder speichern Sie diese Seite als Lesezeichen.

Die Auflösungsregeln für „Wie viele Fälle von neuroinvasiven West-Nil-Erkrankungen werden im Jahr 2026 unter den Bewohnern von New York City gemeldet werden?" definieren genau, was passieren muss, damit jedes Ergebnis als Gewinner erklärt wird – einschließlich der offiziellen Datenquellen zur Bestimmung des Ergebnisses. Sie können die vollständigen Auflösungskriterien im Abschnitt „Regeln" auf dieser Seite über den Kommentaren einsehen. Wir empfehlen, die Regeln vor dem Handeln sorgfältig zu lesen, da sie die genauen Bedingungen, Sonderfälle und Quellen festlegen.